×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Authors
Document Type
Journal article [2]
Date Issued
2022 [2]
Language
英語English [2]
Source Publication
Frontiers in Pha... [1]
Journal of Nanob... [1]
Indexed By
SCIE [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-2 of 2
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma
Journal article
Gu, Yongwei, Du, Yue, Jiang, Liangdi, Tang, Xiaomeng, Li, Aixue, Zhao, Yunan, Lang, Yitian, Liu, Xiaoyan, Liu, Jiyong. αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma[J]. Journal of Nanobiotechnology, 2022, 20(1).
Authors:
Gu, Yongwei
;
Du, Yue
;
Jiang, Liangdi
;
Tang, Xiaomeng
;
Li, Aixue
; et al.
Favorite
|
TC[WOS]:
28
TC[Scopus]:
29
IF:
10.6
/
11.4
|
Submit date:2023/01/30
Crgd
Exosomes
Malignant Melanoma
Targeted Delivery
Triptolide
Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis
Journal article
Liu, Xiaoyan, Lang, Yitian, Chai, Qingqing, Lin, Yan, Liao, Yahui, Zhu, Yizhun. Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis[J]. Frontiers in Pharmacology, 2022, 13.
Authors:
Liu, Xiaoyan
;
Lang, Yitian
;
Chai, Qingqing
;
Lin, Yan
;
Liao, Yahui
; et al.
Favorite
|
TC[WOS]:
4
TC[Scopus]:
4
IF:
4.4
/
5.0
|
Submit date:2023/01/30
Atezolizumab
Cost-effectiveness
Metastatic Urothelial Cancer
Partitioned Survival Model
The Perspective Of The United States And China